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Abstract: Mitochondria are critical for several cellular functions as they control metabolism, cell
physiology, and cell death. The mitochondrial proteome consists of around 1500 proteins, the vast
majority of which (about 99% of them) are encoded by nuclear genes, with only 13 polypeptides in
human cells encoded by mitochondrial DNA. Therefore, it is critical for all the mitochondrial proteins
that are nuclear-encoded to be targeted precisely and sorted specifically to their site of action inside
mitochondria. These processes of targeting and sorting are catalysed by protein translocases that
operate in each one of the mitochondrial sub-compartments. The main protein import pathway for
the intermembrane space (IMS) recognises proteins that are cysteine-rich, and it is the only import
pathway that chemically modifies the imported precursors by introducing disulphide bonds to them.
In this manner, the precursors are trapped in the IMS in a folded state. The key component of this
pathway is Mia40 (called CHCHD4 in human cells), which itself contains cysteine motifs and is
subject to redox regulation. In this review, we detail the basic components of the MIA pathway and
the disulphide relay mechanism that underpins the electron transfer reaction along the oxidative
folding mechanism. Then, we discuss the key protein modulators of this pathway and how they are
interlinked to the small redox-active molecules that critically affect the redox state in the IMS. We
present also evidence that the mitochondrial redox processes that are linked to iron–sulfur clusters
biogenesis and calcium homeostasis coalesce in the IMS at the MIA machinery. The fact that the MIA
machinery and several of its interactors and substrates are linked to a variety of common human
diseases connected to mitochondrial dysfunction highlight the potential of redox processes in the
IMS as a promising new target for developing new treatments for some of the most complex and
devastating human diseases.
Keywords: mitochondria; oxidative folding; redox signaling; Mia40; intermembrane space
1. Introduction
Mitochondria are essential organelles that participate in a diverse range of vital cellular
functions ranging from energy production, to iron, macromolecule, and lipid biosynthesis.
Mitochondria play also a critical role in specific cell death modalities [1–3]. Surrounded by
the outer mitochondrial membrane (OMM) and inner mitochondrial membrane (IMM),
the mitochondrial intermembrane space (IMS) is the smallest sub-compartment of mito-
chondria. The IMS can be further sub-divided into the boundary IMS and the cristae space;
the latter is formed from invaginations of the IMM. The cristae space is separated from
the boundary IMS by cristae junctions (CJs) and contact sites where the OMM and IMM
physically contact each other [4,5]. The diameter of the IMS (OMM to IMM) is around
60 nm. However, this small compartment is the interface between the mitochondrial matrix
and the cytosol, exchanging various proteins, lipids, metabolites, and metal ions, all of
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which play a role in redox regulation [6]. This “controlled exchange” of the IMS is due
to the presence of porins in the OMM, which allow molecules of less than 5 kDa to freely
diffuse, facilitating communication between mitochondria and other areas of the cell [7].
Alongside this “buffering” role between the cytosol and the matrix, IMS proteins are in-
volved in the biogenesis, assembly, and stability of respiratory chain complexes, protein
folding, lipid homeostasis, and the initiation of cell death through the release of proteins
such as cytochrome c [3,8].
Mitochondria contain around 1000 different proteins in Saccharomyces cerevisiae (S. cere-
visiae) and roughly 1400 in humans, yet the yeast and human mitochondrial genome encode
for just seven and 13 proteins, respectively [9]. Therefore, 99% of mitochondrial proteins
are nuclear encoded and require import into their correct location within the organelle. The
main pathways for mitochondrial protein import are the presequence pathway for matrix
proteins and the carrier pathway for IMM proteins. These two major pathways both contain
steps where the IMS plays a crucial role in maintaining the imported preproteins in a re-
duced and unfolded state. The IMS itself contains ≈51 proteins in the yeast S. cerevisiae [10]
and ≈53 in humans [11]. We should note here that a previous estimate for the number
of IMS proteins for human mitochondria brought this number to 127 [12]. The difference
is due to the fact that Rath et al. (2020) annotated proteins that are part of a membrane
complex in their mature form as membrane proteins even though they are IMS-localised
during their biogenesis (leading to a potential underestimation), and the APEX2 proximity
biotinylation used by Hung et al. (2014) labelled not only IMS proteins but also those in
the MOM and MIM that are accessible to the biotin label emanating from the IMS (leading
to a potential overestimation). Interestingly, none of the IMS proteins are encoded by the
mitochondrial genome and therefore require additional import pathways. There are six
main import pathways to the IMS (recently reviewed by Edwards, Gerlich, and Tokatlidis
2020) with the Mia40 oxidative folding pathway (also known as the disulphide relay) being
one of the most wellknown. Additionally, it has been shown that a number of IMS proteins
exhibit dual localisation between the cytosol and the IMS, reinforcing the communication
that occurs between these two locations [7,10].
The MIA (Mitochondrial Import and Assembly) pathway in the IMS is unique as it is
the only pathway that involves chemical modification of cysteine residues and therefore
is potentially subject to regulation through redox signalling. This potential is due to the
sensitivity that the cysteine residues have to redox states due to the presence of anionic
sulfur, which is reactive with different oxidising agents, resulting in multiple oxidised
species [13]. The IMS provides a redox active space that is more oxidising than the cytosol,
and this redox active space allows for the formation of disulphide bonds through oxidative
folding. Additionally, the redox environment in the IMS is maintained separately from the
cytosol and the matrix [14]. Disulphide bond formation occurs also in the endoplasmic
reticulum (ER) of mammalian cells and the periplasm of bacteria where a balance between
an oxidative and reductive pathway is needed for optimal regulation of the redox process.
However, unlike those compartments, a reducing pathway in the IMS is yet to be fully
described [15]. In broader terms, the concept that mitochondria biogenesis is subject to cell
signalling pathways is fast gaining momentum, spurred by numerous important studies in
the field. Phosphorylation signalling is an important signalling pathway that is linked to
mitochondria biogenesis [16] but will not be described in this review. Here, we will focus
on the basic players and protein modulators of the MIA pathway with an emphasis on
redox regulation. Additionally, we will discuss the small redox molecules in the IMS and
their interplay with proteins controlling the IMS-located import machinery.
2. The MIA Pathway—Basic Players and Mechanism
The redox active environment of the IMS promotes the oxidation of cysteine residues,
which ultimately leads to the formation of disulphide bonds. These disulphide bonds are
formed in substrate proteins that are imported into the IMS, in a reaction where the thiol
groups of two cysteine residues are oxidised, forming a covalently linked intramolecular
disulphide. It is through the process of oxidative folding where a protein acquires its native
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disulphide bonds and therefore its native three-dimensional structure [17,18]. The MIA
pathway in the IMS introduces disulphide bonds to imported proteins through oxidative
folding, which allows the retention of the proteins in the IMS in an oxidised and folded
state (Figure 1). The pathway is comprised of two essential proteins, the oxidoreductase
Mia40 (CHCHD4 in mammals) [17,19] and the flavin adenine dinucleotide FAD-dependent
sulfhydryl oxidase Erv1 (ALR, Augmenter of Liver Regeneration, in humans) [20]. This
section will focus on the key players and the basic mechanisms of the regulation of this
import pathway, which was initially discovered in the yeast model organism.
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Figure 1. Mechanism and basic players of the MIA pathway. Incoming nuclear-encoded and cysteine-
bearing proteins destined for the intermembrane space (IMS)-localised MIA pathway are firstly
translocated through the Tranlocase of the Outer Membrane TOM complex. The ITS (IMS-Targeting
Signal, shown in purple) interacts with Mi 40 through the “sliding–docking” model. Following
interaction with Mia40, the substrate is released in an oxidised and stably folded conformation. The
Cysteine-Proline-Cysteine CPC motif of Mia40 is left in a reduced state and requires re-oxidation
to continue participating in import reactions. The re-oxidation of Mia40 is facilitated by Erv1, and
then, the electrons are passed directly to molecular oxygen (resulting in the production of hydrogen
peroxide), or to cytochrome c and respiratory chain complex IV in aerobic conditions, or to Osm1 in
anaerobic conditions. Overall, the MIA pathway inserts disulphide bonds into proteins, trapping
them in the IMS of mitochondria.
Mia40 contains six strictly conserved cysteine residues that are organised as a redox-
sensitive CPC motif and two CX9C motifs. These two CX9C motifs stabilise the protein
and form a hydrophobic cleft of two anti-parallel helices to bind the substrate. The solvent-
exposed CPC motif constitutes the redox-active cysteine pair of Mia40 that accepts electrons
shuttled from the su strate pro ein and introduces the d sulphide bond whilst switching
be ween a reduced and xidised state [17,19,21,22].
Classical Mia40 substrates typically have a small mass of between 8 and 22 kDa,
a hydrophobic intermembrane space targeting signal (ITS), and either twin CX3C or CX9C
motifs, such as the family of Tim proteins [23–25]. Other non-typical Mia40 substrates
contain different patterns of cysteine residues, for example, the protein Mix23 contains a
CX13C/CX14C motif. This indicates that the MIA pathway interacts with a broader range
of cysteine motifs [10,26].
To reach the IMS, proteins must pass first through the OMM and, in the MIA pathway
protein, substrates are translocated through the TOM complex in an unfolded and reduced
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conformation which renders them import-competent [18]. During translocation into the
IMS (Figure 1), substrate proteins bind to Mia40 via specific docking cysteines, which
further drives the import process [27,28]. The mechanism of interaction between Mia40 and
the substrate protein involves an IMS-targeting signal (ITS), which is an internal peptide of
nine amino acids that forms an amphipathic helix. First described in the protein substrates
Tim9 and Tim10, the ITS is sufficient for crossing the OMM and has a complementary
fit to the cleft of Mia40 through hydrophobic interactions [25,29]. The mechanism of
interaction between Mia40 and the imported protein can be explained by the “sliding–
docking” model where the first “sliding” step involves positioning the ITS of the imported
protein in the cleft of Mia40 through non-covalent hydrophobic interactions. This initial
interaction between the ITS and the hydrophobic cleft, due to the close proximity and
correct orientation, leads to the subsequent “docking” step, which involves the formation
of a transient intermolecular bond between Mia40 and the substrate, which is mediated
by the second cysteine of the CPC motif of Mia40 and the docking cysteine of the ITS
signal of the substrate [25,30]. Then, this transient intermolecular disulphide is subjected
to nucleophilic attack by the other cysteine of the substrate, creating an intramolecular
disulphide within the substrate. Following this, the substrate is released from Mia40 in
an oxidised, stably folded conformation, thereby remaining trapped in the IMS. The CPC
motif of Mia40 is left in a reduced state and requires re-oxidation to restore its capacity to
import substrate proteins [21,25,31].
This is where the second essential component of the MIA pathway Erv1 comes into
play and re-oxidises Mia40 for another cycle of disulphide bond formation (Figure 1). Erv1
is a 22 kDa flavin-linked sulfhydryl oxidase that is present in a head-to-tail dimer in the IMS.
The basic role of Erv1 in the disulphide relay is to re-oxidise Mia40. Mutated or knockout
Erv1 cells have reduced levels of Tims and other small IMS-localised substrate proteins,
highlighting the importance of Erv1 in IMS protein import [20]. It has been reported that
the evolutionary conserved human homolog of yeast Erv1 (ALR) can complement its yeast
counterpart for the function of oxidative biogenesis of mitochondrial IMS proteins [32].
Erv1 family members have a core domain of ≈100 amino acids that are arranged in a four-
helix bundle structure with FAD bound non-covalently for stabilisation. The FAD-binding
domain contains the stabilising proximal disulphide (C130/133) in the redox active CXXC
motif [33,34]. The first pair (C30/33) is the shuttle disulphide, which is located at the N-
terminus and interacts with Mia40, whilst the third (C159/176) is the structural disulphide
that is recognised by Mia40 during Erv1 import. This N-terminal shuttle domain of Erv1 is
sufficient and necessary for the non-covalent interaction of Mia40 and Erv1 [31,35–39].
Oxidised Erv1 interacts with reduced Mia40 following a “substrate mimicry” model
where the N-terminal segment of Erv1 (about 72 residues) interacts with the hydrophobic
binding groove of Mia40 in a similar manner to the ITS of the substrate, accepting the
electrons via its N-terminal redox active CPC motif [38,40]. Then, Erv1 can transfer these
electrons either directly to oxygen, which results in the production of hydrogen peroxide
in the IMS, or to cytochrome c and complex IV of the respiratory chain (Figure 1) [41–45].
Alternative final electron acceptors such as Osm1 in yeast allow the process to proceed
under anaerobic conditions [46]. Recent evidence has suggested that Erv1 is perhaps not as
active as previously thought and has been shown to be a moderately efficient enzyme, being
able to use both O2 and cytochrome c as electron acceptors. Such a moderate efficiency
could be due to the slower kinetics of protein import and disulphide bond formation,
which places no pressure on the requirement for a higher catalytic efficiency [47].
It is worth mentioning that Mia40 requires and interacts with endogenous Mia40
for its own import into the IMS. The import of Mia40 occurs in kinetically distinct steps;
firstly, Mia40 translocates through the TOM complex, and it is then inserted into the IMM
by the TIM23 complex [48]. Secondly, the core of Mia40 is folded with assistance from
endogenous Mia40 through oxidation of the structural CX9C motif. Lastly, there is an
interaction with Erv1 to oxidise the CPC motif of Mia40 resulting in a folded and active
Mia40 [8,48]. Intriguingly, Erv1 itself is imported via Mia40, but it is not a classical Mia40
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substrate, as import is mediated by its CX15C motif found towards the C-terminus of the
protein rather than the FAD-proximal CXXC or the N-terminal CXXC shuttle motif [24,37].
Overall, the MIA pathway is responsible for inserting disulphide bonds into proteins,
trapping them in the IMS. Similar to the disulphide relay systems in the ER and bacterial
periplasm, electrons are transferred from the substrate onto Mia40, then Erv1, and onto a
final electron acceptor with Mia40 being re-oxidised in the process (Figure 1). However,
unlike the disulphide relay in the ER and bacterial periplasm, the process of disulphide
bond insertion in the IMS has no reductive pathway described yet. In 2012, it was reported
that in the IMS proteome of yeast mitochondria, the cytosolic reductive system, thiore-
doxin 1 (Trx1), and its partner thioredoxin reductase 1 (Trr1) are present [10]. This raises
questions around the function of these proteins in the IMS and any potential regulatory
role, either directly or indirectly, on Mia40 through influencing the redox environment of
this sub-compartment.
3. The Mia40/CHCHD4 Machinery in Human Cells
Mia40 exists in the IMS as either a soluble protein in higher eukaryotes or anchored
through its N-terminal in fungi and yeast (although this membrane anchor is not essential
for function). The evolutionary conserved human homolog of yeast Mia40 is the small
(16 kDa) IMS-soluble CHCHD4 (Coiled-Coil-Helix-Coiled-Coil-Helix Domain Contain-
ing 4) [17,49]. Compared to the membrane-bound Mia40, the CHCHD4 protein has lost its
N-terminal moiety that includes the mitochondrial targeting signal (MTS) and the trans-
membrane domain (TMD), while conserving the C-terminal functional segment that carries
the signature CPC and twin CX9C motifs [17,21,26,49,50]. The functional conservation
between the two proteins was confirmed by means of RNA interference silencing in human
cells and complementation assays demonstrating that CHCHD4 is imported in yeast and is
perfectly capable of rescuing the MIA import pathway and cell viability in yeast mutants
suppressed for Mia40 [49,51]. While the above-mentioned data were clear indicators of
a perfect functional conservation of Mia40/CHCHD4 during the evolution from yeast to
man, the absence of the N-terminal segment in the human CHCHD4 protein revealed a
major change in the regulation of its biogenesis as well as its capacity to interact with other
proteins. Probably one of the most prominent consequences of the loss of the N-terminal
MTS and TMD segments is the switch in the molecular mechanisms of the mitochondrial
import of the protein. More precisely, contrary to its yeast homolog, CHCHD4 is no longer
imported through the activity of the TIM23 translocase in a membrane potential-dependent
manner but rather depends on a self-catalytic import mechanism [21,22,49,51,52]. So far,
the advantage that this import mechanism shift offers is elusive, but one can speculate
that in specialised cells of higher eukaryotes, the redox-regulated import of CHCHD4
would enable an efficient adaptation of the Mia40/CHCHD4 pathway to physiological
signals or specific stress conditions. The second noticeable characteristic of CHCHD4
that differentiates it from its yeast homolog is the gain of capacity to interact with the
IMM-bound flavoprotein called Apoptosis-Inducing Factor (AIF) [52,53]. The evolutionary
advantage of the interaction between CHCHD4 and AIF is not understood, but the data
published so far indicate that AIF is needed for the co-translational import of CHCHD4 in
the IMS [52]. While the N-terminal 27 residues of CHCHD4 is necessary and sufficient for
the physical interaction with AIF [52], the negatively charged C-terminal portion of the pro-
tein was found to be critical for fine tuning of the import kinetics and for protection against
proteasomal degradation during the import process [54]. In mammals, the AIF-regulated
optimal functioning of the CHCHD4/Mia40 import pathway is essential for the biogenesis
of the respiratory chain protein complexes [52,53]. In various experimental models, it was
shown that the loss of AIF provokes a bioenergetics dysfunction that is mainly caused
by CHCHD4 protein deficiency and the subsequent loss of CHCHD4 substrates [26,55].
AIF mutations have been associated with human neurodegenerative mitochondriopathies,
and, among these, AIF G308E and dR201del are described for their potential to perturb the
AIF/CHCHD4 import pathway [52,53]. The essentiality of the CHCHD4/Mia40 mitochon-
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drial import pathway in higher eukaryotes is reflected by the embryonic lethality, which is
caused by the homozygous knockout of Aif or chchd4 genes [55,56].
4. Redox Proteins Interacting with the MIA Machinery
As mentioned previously, the MIA pathway is unique, as it is the only import pathway
that chemically modifies its substrates, resulting in intramolecular disulphide bonds. This
potentially opens up this pathway to regulation by the redox environment of the cell, which
is determined by all the oxidative and reductive reactions that occur. Redox reactions
produce reactive oxygen species (ROS) and reactive nitrogen species (RNS), which are
beneficial for cell signalling at low levels but damaging at high levels. These damaging
effects can include DNA modification, protein oxidation, and lipid oxidation, all of which
are detrimental to cell function and can lead to cell death [31,57]. The balance between the
production and removal of these reactive species has a direct influence on vital cellular
processes such as protein biogenesis, which is of particular importance for mitochondria,
as ≈99% of mitochondrial proteins require import [15].
Redox signalling is crucial, as it allows cells to rapidly adapt to a range of environ-
mental stimuli. The cellular redox status is maintained by several antioxidant systems,
primarily the thioredoxin (Trx) and glutaredoxin (Grx) systems. Redox signals produced
by the essential functions of mitochondria such as oxidative phosphorylation (OXPHOS),
fatty acid oxidation, and the synthesis of iron–sulfur clusters allow mitochondria to be
integrated into the wider cellular context through the free diffusion of small molecules
between the IMS and the cytosol via the semi-permeable OMM [58]. It is also important to
note that the redox environment of the mitochondrial IMS is separately maintained from
the cytosol and the matrix with each compartment being separately influenced by various
factors [14]. This section of the review will focus on the protein modulators of Mia40 in the
IMS including Gpx3, Hot13, Trx1, and their potential role(s) in regulating Mia40 functions
(Figure 2).
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Figure 2. Protein factors modulating Mia40. AIF (Apoptosis-Inducing Factor) controls the import of
CHCHD4 (Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 4) in human cells. Gpx3 has an
oxidising effect. Trx1 has a reducing effect as thioredoxins catalyse the protein disulphide exchange
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communication between these two systems. Erv1, and its human homologue ALR, have an oxidising
effect on Mia40/CHCHD4 and are responsible for re-oxidising the CPC motif of Mia40 as part of the
oxidative folding process in the IMS. Cells with mutated/knocked down Erv1 have reduced levels of
MIA substrate import.
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4.1. Glutathione Peroxidase 3 (Gpx3)
Glutathione peroxidase 3 (Gpx3, also called Orp1 and Hyr1) is a thiol peroxidase
and was one of the redox regulatory protein identified in the 2012 yeast IMS proteome
study [10]. Gpx3 acts as a sensor for H2O2 within the cell and promotes the oxidation
of the transcription factor Yap1 [59]. This leads to the formation of an intramolecular
disulphide bond of Yap1 and its subsequent activation, occurring when there is an increased
level of H2O2 that directly oxidises the Cys36 of Gpx3. Then, Gpx3 forms a transient
intermolecular disulphide with Cys598 of Yap1, which is then oxidised and activated. Then,
Yap1 translocates to the nucleus and induces the anti-oxidant response, which leads to the
transcription of anti-oxidant response genes. This pathway is attenuated by thioredoxin,
which reduces the disulphide in Gpx3 that is formed by an increase in H2O2 levels [59].
Gpx3 has a molecular weight (MW) of ≈26 kDa and undergoes alternative translation
under H2O2 stress to form an 18-amino acid N-terminal (N18)-extended version of the
protein that was identified as being targeted to the mitochondrial IMS [60,61]. This N-
terminal 18 amino acid extension is encoded by a non-AUG codon and is capable of
targeting other proteins to mitochondria both in vivo and in organello. Cells that lacked
Gpx3 had aberrant mitochondrial morphology (displaying a “dumbbell” shape), along
with decreased protein import and a lower IMM potential. These abnormal phenotypes
could be reversed by expression of the mitochondria-targeted Gpx3. Note that Gpx3, which
lacks the N18 extension, can also be imported into mitochondria with the import of both
the extended and non-extended forms of Gpx3 being mostly unaffected by a lack of Mia40.
This suggests that Gpx3 import is independent of Mia40 (an essential gene), and therefore,
the protein has an unconventional IMS import mechanism. Furthermore, Gpx3 can interact
with Mia40 to oxidise its reduced form, therefore maintaining its redox state as oxidised,
with Gpx3 becoming rapidly reduced following incubation with Mia40 (Figure 2) [61].
Overall, these data suggest a mitochondria-specific role of Gpx3 in the IMS where it could
interact with the IMS-localised Trx1 as the source of the reducing power for Gpx3 in this
compartment, essentially mirroring the redox system of the cytosol.
4.2. Helper of Tim Protein 13 (Hot13)
Another modulator of Mia40 is the soluble IMS protein Hot13, which is a non-essential
player of the MIA pathway, instead having an ancillary role. Hot13 is conserved among
eukaryotes, contains 10 cysteines, and has a CHY zinc-finger domain, which provides
the capacity to bind zinc [62]. Hot13 has been proposed to maintain Mia40 in a zinc-
free state, thereby allowing for a more efficient re-oxidation by Erv1. Hot13 mutants
have an increased sensitivity to the oxidising agent t-butyl hydroperoxide and impaired
import of Mia40 substrates, leading to suggestions that Hot13 plays a role in IMS redox
regulation. Additionally, Hot13 mutants, when compared to wild-type cells, have a greater
level of reduced Mia40 but no difference in overall levels of Mia40 and Erv1. This leads
to a proposed model where Hot13 acts as a metal chaperone to transfer zinc ions from
Mia40 allowing for re-oxidation by Erv1 [63]. In conclusion, Hot13 has an important
yet non-essential role in regulating the redox environment of the IMS and the process of
oxidative folding.
4.3. Thioredoxin and Glutaredoxin
The thioredoxin system is comprised of thioredoxin (Trx), thioredoxin reductase (TrR),
and nicotinamide adenine dinucleotide phosphate (NADPH) as an electron donor. S. cere-
visiae contains three thioredoxins (Trx1, Trx2, and Trx3) and two thioredoxin reductases
(Trr1 and Trr2) [64]. Trx3 and TrR2 are located in the mitochondrial matrix, while Trx1
and Trx2 are responsible for the cytosolic pathway. This system is crucial for regulating
oxidative stress by providing electrons to the peroxiredoxins to remove ROS/RNS. Thiore-
doxins are small reductases (≈12 kDa) that catalyse disulphide exchange of proteins with a
conserved CGPC motif in their active site. The characteristic thioredoxin fold is common
between other proteins that modify thiol redox states such as glutaredoxins, and the basic
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structure of this fold is comprised of three alpha helices that surround four beta sheets
with an active CX2C motif. The mechanism of the Trx system is similar to the Grx system
with electrons being transferred by Trx to the substrate through thiol–disulphide exchange
reactions [15].
Interestingly, Trx1 has previously been shown to directly interact with Mia40 in a large
proteomic screen [65]. Trx1 along with Trr1 have been shown to dually localise in the IMS
and the cytosol [10], raising the possibility that Trx1 is involved in influencing the IMS
redox environment [61].
The process of disulphide bond formation is error-prone, and therefore, it seems
logical that a reductase system would be present in this constricted sub-compartment in
yeast mitochondria to allow for disulphide isomerisation as a means to achieve the correct
disulphide bonds in IMS proteins. The reducing enzyme glutaredoxin 1 (GRX1) in the IMS
was shown to modulate the oxidation of COX17 (a copper chaperone for the Cytochrome c
Oxidase or COX complex), which is a mammalian Mia40 (CHCHD4) substrate [66]. Trx1
could conceivably have a similar role in yeast mitochondria, acting on Mia40 substrates
to ensure the optimal functioning of the MIA pathway. This may not be required for all
substrates but rather substrates with several cysteine residues, which have a more complex
cysteine pair pattern. It has previously been suggested that this is logical, because the
Grx and Trx reducing pathways can compensate for each other due to their overlapping
functions, while the two are often found in the same compartments [55].
Further research is required to identify the interplay and communication of the
mitochondrial-targeted Gpx3 and the levels of Trx1 in the IMS. It will be interesting to see
how these two proteins act to influence the redox environment of this sub-compartment,
especially as Erv1 has recently been identified to not be as active as previously thought [47].
A summary of the important proteins that are involved in redox regulation and signalling
in the mitochondrial IMS as discussed in this section is given in Table 1.
Table 1. Important proteins involved in redox regulation and signalling in the mitochondrial IMS discussed in this review.
Protein Name Function References
Mia40/CHCHD4
Oxidoreductase donates a disulphide bond from its CPC motif to the substrate
proteins, thereby catalysing their oxidative folding. Mia40/CHCHD4 requires
re-oxidation to undergo another round of oxidative folding.
[10,17–23,25–31,49–56]
Erv1/ALR
FAD-dependent sulfhydryl oxidase, responsible for re-oxidising
Mia40/CHCHD4 to allow another cycle of disulphide bond formation on the
protein substrates. Electrons from the reduced Mia40/CHCHD4 CPC motif
flow to the N-terminal shuttle CX2C motif of Erv1/ALR, following a
“substrate mimicry” mechanism.
[20,24,31–47,52]
Gpx3 (also called Orp1
and Hyr1)
A thiol peroxidase acting as an H2O2 sensor and promotes the oxidation of the
transcription factor Yap1 in the cytosol, inducing the anti-oxidant response.
Gpx3 undergoes alternative translation under H2O2 stress, forming an




Hot13 is conserved amongst eukaryotes, but it is a non-essential protein. It is
associated with the MIA pathway as it allows a more efficient re-oxidation of
Mia40 by Erv1, potentially by maintaining Mia40 in a zinc-free state.
[62,63]
Thioredoxin
Thioredoxins are ubiquitous proteins with a major role in regulating oxidative
stress by providing electrons for the removal of ROS/RNS and reducing
disulphide bonds. Trx1 is dually localised between the cytosol and the IMS. It
interacts with Mia40, and it may influence the redox environment of the IMS.
[10,15,61,64,65]
Glutaredoxin
Glutaredoxin has a similar mechanism to thioredoxin, transferring electrons to
the substrate proteins through thiol–disulphide exchange reactions. Grx1 is
also a reducing enzyme and modulates the oxidation of COX17, which is a
Mia40 substrate.
[15,55,66]
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5. Small Redox Molecules and Redox Homeostasis in the IMS
In addition to protein modulators of the redox environment in the IMS, there are
also small molecules that play a role in redox regulation. These small molecules include
hydrogen peroxide (H2O2) and glutathione (GSH), which act as signals and are important
for initiating the redox response of the cell. H2O2 is classified as a reactive oxygen species
(ROS), which are produced through normal cell metabolism and also include the superoxide
anion (O2−) and the hydroxyl radical (OH−), which are all associated with oxidative
stress [57]. ROS can act as signalling molecules by oxidising cysteine residues and forming
disulphide bonds, which results in the alteration of a protein structure and therefore
function. These disulphide bonds can be reversed by the disulphide reductases Trx and
Grx, and this reversibility allows for the rapid alteration of protein function in response
to ROS [57,67]. In the IMS, GSH has reducing activities and H2O2 has oxidising activities,
and they both have a role in maintaining the redox environment of the IMS. In this section
of the review, we will discuss potential dialogues between these molecules and the MIA
pathway (Figure 3).
Antioxidants 2021, 10, x FOR PEER REVIEW 9 of 20 
 
terminally extended version that is targeted to the IMS. 
Gpx3 can reoxidise reduced Mia40. 
Hot13 
Hot13 is conserved amongst eukaryotes, but it is a non-es-
sential protein. It is associated with the MIA pathway as it 
allows a more efficient re-oxidation of Mia40 by Erv1, po-
tentially by maintaining Mia40 in a zinc-free state.  
[62,63] 
Thioredoxin 
Thioredoxins are ubiquitous proteins with a major role in 
regulating oxidative stress by providing electrons for the 
removal of ROS/RNS and reducing disulphide bonds. 
Trx1 is dually localised between the cytosol and the IMS. 
It interacts with Mia40, and it may influence the redox en-
vironment of the IMS.   
[10,15,61,64,65] 
Glutaredoxin 
Glutaredoxin has a similar mechanism to thioredoxin, 
transferring electrons to the substrate proteins through 
thiol–disulphide exchange reactions. Grx1 is also a reduc-
ing enzyme and modulates the oxidation of COX17, 
which is a Mia40 substrate.  
[15,55,66] 
5. Small Redox Molecules and Redox Homeostasis in the IMS 
In addition to protein modulators f the redox environment in t  IMS, there are also 
small molecules that play a role in redox regulation. These small molecules include hy-
drogen peroxide (H2O2) and glutathione (GSH), which act as signals and are important for 
initiating the redox response of the cell. H2O2 is classified as a reactive oxygen species 
(ROS), which are produced through normal cell metabolism and also include the super-
oxide anion (O2−) and the hydroxyl radical (OH−), which are all associated with oxidative 
stress [57]. ROS can act as signalling molecules by oxidising cysteine residues and forming 
disulphide bonds, which results in the alteration of a protein structure and therefore func-
tion. These disulphide bonds can be reversed by the disulphide reductases Trx and Grx, 
and this reversibility allows for the rapid alteration of protein fu ction in response to ROS 
[57,67]. In the IMS, GSH has reducing activities and H2O2 has oxidising activities, an  they 
both have a role in maintaining the redox environment of the IMS. I  this section of the 
review, we will discuss potential dialogues between these molecules and the MIA path-
way (Figure 3). 
 
Figure 3. Small molecules affecting redox homeostasis in the IMS. Glutathione (GSH) has a reducing
effect on Mia40/CHCHD4. H2O2 has an oxidising effect on Mia40/CHCHD4 and can easily cross
mitochondrial membranes. NADPH has a reducing effect on Mia40/CHCHD4 and is utilised by
the two main thiol-reducing pathways in the cell, the Trx and Grx pathways. Cytosolic NADPH
has recently been implicated in the regulation of the newly discovered OMM channel protein Ayr1,
whose function remains unknown. Small molecule structures were obtained from PubChem and
visualised in Chimera version 1.15.0. PubChem CIDs are as follows; NADPH (5884), glutathione
(124886) and H2O2 (784).
5.1. The Oxidant Hydrogen Peroxide (H2O2)
Reactive oxygen species are normally produced as by-products of cellular respiratory
metabolism and can be harmful to cells when their concentrations are very high. Here, we
focus on H2O2 in the IMS, its sites of production, and its influence on the redox state of the
IMS: other ROS and RNS will be discussed briefly in subsequent sections. H2O2 is derived
from the partial reduction of molecular oxygen and is more stable and less reactive than
the ROS superoxide anion (O2−) because it does not contain unpaired electrons. Instead
the reactivity of H2O2 is provided by its relatively weak O–O bond, which is susceptible
to decomposition, resulting in the formation of a hydroxyl radical (OH−), which is very
reactive [68,69].
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H2O2 (and/or O2−) are produced by up to eleven distinct sites in mammalian mi-
tochondria. These sites include processes such as the electron transport chain (ETC) and
substrate oxidation, which have been covered extensively in a review elsewhere [70]. Gener-
ally, H2O2 is generated in places where there is a leakage of pairs of electrons, and there are
various antioxidant defence systems in place to consume H2O2 and prevent damage to the
cell. Additionally, H2O2 can easily pass through mitochondrial membranes, meaning that
H2O2produced in the matrix can travel to the IMS through the IMM. This both increases the
level of H2O2 in the IMS and may have a role in signalling to the cell through the buffering
function of the IMS. H2O2 is generated in the IMS several ways. The copper–zinc isoform
of Superoxide dismutase 1 (SOD1), which catalyses the rapid dismutation of two molecules
of O2− to produce H2O2 and O2, is present in the IMS. Superoxide anions are released to
the IMS side of the IMM by various enzymes of the respiratory chain, notably complex
III [5]. Additionally, the Erv1/ALR enzyme in its normal catalytic cycle also produces
H2O2. During this process, Erv1 can pass the electrons directly to molecular oxygen with a
concomitant production of H2O2. Daithankar et al. (Biochemistry 2009) first showed that
Erv1 interacts with cytochrome c in vitro [44]. Allen et al. (J Mol Biol 2005) demonstrated
that also in intact cells, cytochrome c (cyt c) is the in vivo oxidase for Erv1, as yeast cells
mutated in cyt c cannot grow under anaerobic conditions. This demonstrated that Erv1
functionally links the Mia40-dependent import pathway to the Mia40-independent cyt
c import pathway by transferring electrons from the incoming precursors to cyt c as an
acceptor [41]. Later, Bihlmaier et al. in 2007 proposed that the interaction between Erv1 and
cytochrome c may protect the cell from oxidative damage, as avoiding passing the electrons
to molecular oxygen prevents H2O2 formation. It was concluded that this interaction
allowed for electrons to be passed to the respiratory chain, which led to the production
of water instead of H2O2 and simultaneously connected the ETC to the redox state of
the IMS [42]. To remove H2O2 in the IMS, cytochrome c peroxidase (Ccp1) reduces the
harmful H2O2 to water [43]. Additionally, the recently unconventionally targeted Gpx3
may also have a role in removing H2O2as thiol peroxidases are major antioxidants in cells
and protect against H2O2 caused oxidative stress [61]. Both Ccp1 and Gpx3 can interact
with components of the MIA pathway and are therefore capable of removing H2O2 from
this process and the IMS [47].
In terms of signalling, H2O2 can directly oxidise select cysteine residues to induce
signalling and is thought to be broadly non-specific. This oxidation of cysteine thiol groups
can lead to structural changes in the protein, which can lead to a change of function.
As mentioned above, Trx1 is capable of reducing these disulphide bonds with both Trx1
and Trr1 being identified in the IMS [10]. In the IMS, there is the potential for high local
concentrations of H2O2 to manifest both from invaginations of the IMM and from the
presence of respiratory chain enzymes [5]. Further study is required to determine which of
the ≈51 IMS proteins in yeast and ≈127 in humans can be directly oxidised by H2O2 in
mitochondria, and any effects of H2O2 diffusion through pores in the OMM may have on
signalling between mitochondria and the cell. Interestingly, it has been reported that H2O2
signalling may be under the control of a signal transduction pathway, which links the ETC
to the IMS-localised Syk pathway, with H2O2 inducing the phosphorylation of Syk. The
authors suggest that this connection between the respiratory chain and the conserved Syk
pathway produces a focused signalling response to the cell; however, only extracellular
H2O2 was used in this study [68]. Nonetheless, it is important to appreciate the wider
signalling aspect of H2O2 and not just the potential damage it can cause in cells.
The design of mitochondrial targeted reagents that are capable of independently
inducing O2− and H2O2 or disrupting mitochondrial thiol homeostasis (mitoParaquat and
MitoChlorodinitrobenzoic acid respectively) will allow for further study into the effects of
these process in the mitochondria [71]. Overall, H2O2 has an oxidising effect in the IMS,
with signalling functions between the mitochondria and the wider cell. In the future, it
will be interesting to look at any interplay between a potential reducing system in the IMS
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(Trx1 and Trr1) and H2O2 for maintaining the redox status of the IMS for optimal oxidative
folding conditions (Figure 3).
5.2. The Reductant Glutathione (GSH)
GSH is a component of the glutaredoxin system, which contains glutaredoxins (Grx)
and GSH reductases (GR). The glutaredoxin system is one of the major pathways that
controls cellular redox homeostasis, in addition to the thioredoxin pathway. GSH has
various key roles in reducing disulphide bonds, modulating iron–sulfur clusters biogenesis,
and detoxifying ROS. Participating in these reactions frequently leads to the oxidation of
GSH to GSSG, which contains a disulphide bond that links two molecules of GSH together,
whilst the targets of GSH are left reduced. GSSG is reduced back to GSH by glutathione
reductase (Glr) using electrons supplied by NADPH [45,72]. It is important to note that
no GSH reductase has been found in the IMS. It has consequently been proposed that
once GSH is oxidised to GSSG in this compartment, it is removed through porins and
the TOM channel in the OMM. However, conclusive evidence supporting this GSH efflux
mechanism from the IMS into the cytosol is still missing. GSH is synthesised in the cytosol
and is imported into the mitochondria presumably through the TOM complex and porins
in the OMM, which allow the free diffusion of small molecules. Additionally, there is a
portion of this GSH that could be transported further to the matrix, likely through IMM
carriers [45], although such specific IMM transporters have not yet been identified.
In cells, the majority of glutathione is in the reduced form GSH, and the ratio of
GSH to GSSG (GSH:GSSG) is an indicator of oxidative stress, with a greater level of stress
increasing the ratio of GSSG:GSH. This ratio varies throughout the cell, and understanding
the local glutathione redox potential (EGSH) is key to further untangling the influence of
redox processes. In 2012, Kojer et al. demonstrated that the GSH redox potential in the
IMS is linked to the cytosol, with both compartments having a similar EGSH. They found
that EGSH in the IMS is determined by the glutathione reductase system in the cytosol with
the two pools of GSH being kinetically connected. Furthermore, EGSH in the matrix is
regulated separately from the cytosol and the IMS. Interestingly, they reported that the
local EGSH has a role in maintaining the partially reduced redox state of Mia40, which is
found to be around 70% oxidised. When Erv1 was depleted in cells, Mia40 was found to
be increasingly reduced, which could be due to the GSH pool in this compartment [45].
However, the IMS can be further subdivided into the boundary IMS and cristae space,
which could account for even further local variations in EGSH.
In the IMS, where disulphide bond formation takes place, GSH is responsible for recy-
cling Grx back to its reduced active state, which can then reduce protein thiols. Note that the
IMS contains the dithiol glutaredoxins Grx1 and Grx2, which catalyse S-glutathionylation,
as well as Gpx3, Trx1, and Trr1 as mentioned above, but not its own glutathione-related
enzymes [10,72]. Grx2 has been identified as the main Grx in the IMS of yeast mitochondria
and was proposed to aid oxidative folding, despite the reducing GSH pool [73]. The process
of S-glutathionylation involves a covalent disulphide bond between a molecule of GSH
and the cysteine residue of a protein. Through this post-translational modification, cysteine
residues in IMS proteins could be modified by ROS and RNS, with implications for redox
signalling. Recently, it has been proposed that human Mia40 (CHCHD4) undergoes glu-
tathionylation, which is then capable of transferring electrons directly to cytochrome c [74].
These authors suggest that glutathionylation of human Mia40 occurs to control the levels of
ROS levels normally produced by electron transfer complexes III and IV. Additionally, GSH
in the IMS has been proposed to be an important factor for the efficiency of the oxidative
folding pathway by (i) increasing the speed of import into this sub-compartment [73] and
(ii) providing a proofreading function within the disulphide relay process [75]. However,
in vivo data for such a function in the IMS are still lacking. We should note that although
GSH plays important roles in redox homeostasis in the IMS (Figure 3) and the rest of the
cell, an alternative model has been proposed in which the main role of GSH is to act as a
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key modulator of iron metabolism, while modulating the thiol state would be an ancillary
role [76].
5.3. NADH/NADPH
Nicotinamide adenine dinucleotide (NAD+), reduced Nicotinamide adenine dinu-
cleotide (NADH), nicotinamide adenine dinucleotide phosphate (NADP+), and reduced
nicotinamide adenine dinucleotide phosphate (NADPH) are now well established as impor-
tant enzyme cofactors and signalling mediators of fundamental metabolic and biosynthetic
processes and antioxidant functions in the cell [77]. Recent studies in living cells, performed
by means of genetically modified cells and compartment-specific fluorescent probes, have
further confirmed the spatio-temporal control of NADH and NADPH homeostasis in spe-
cific subcellular compartments such as the nucleus, cytoplasm, and mitochondria, thereby
highlighting the importance of these molecules in compartment-specific local metabolic
processes [77]. In this section of the review, we will discuss potential connections be-
tween NADH/NADPH-regulated processes and the redox-regulated MIA pathway in the
mitochondrial IMS (Figure 3).
NADPH, which functions as a cofactor and electron donor, is implicated in energy
metabolism, biosynthetic pathways, and in the regeneration of the antioxidant capacity of
the cell. NADPH-dependent redox systems are controlled by pools of NADPH produced
mainly in the cytoplasm and mitochondrial matrix [77]. Published reports point toward
a role for cytosol-generated NADPH and NADPH-dependent Glr1 in the regulation of
the pool of GSH that is transported to the IMS via porins’ activity in the OMM of mito-
chondria [45]. As the cytosol-dependent GSH redox potential influences the redox state of
the IMS-localised Mia40 [45], it will be interesting in the future to elucidate further links
between the potential reducing systems in the IMS and the cellular redox state. This is
particularly relevant, since the Trx system (which has been found to dually localise in the
cytosol and the IMS) also operates under the control of NADPH.
Reports indicate that NADPH may control the transport of other, yet unknown small
molecules and/or metabolites via OMM channels such as the newly discovered, NADPH-
regulated, 1-acyldi-hydroxyacetone-phosphate reductase (Ayr1). The function of Ary1
remains unknown, including what the channel is responsible for transporting. The presence
of NADPH was reported to stimulate the frequency of channel gating between different
states, and in the absence of NADPH, the potential of the channel was reversed [78].
Therefore, there may be regulated traffic in and out of the IMS that is under the control of
cytosolic NADPH and hence redox state control.
In human cells, an NAD(P)H-dependent redox process was also found to influence the
interaction of the human homolog of Mia40 (CHCHD4) with its regulatory partner AIF [52].
The flavoprotein AIF, which carries a central NAD+/NADH binding segment, exists
both in monomer and dimer forms in the mitochondrion [79–87]. Upon the interaction
of AIF with NADH or NADPH, the monomer/dimer equilibrium shifts towards the
dimer. The interaction of NAD(P)H with AIF triggers the formation of dimeric and
stable FADH-NAD(P) charge-transfer complexes (CTC) that are not efficient in electron
transfer [82–87]. Hangen et al. in 2015 showed that the conformational state of AIF, which
is promoted by the binding of reduced pyrimidine nucleotides (NADH or NADPH), favors
its interaction with CHCHD4 [52]. Although it is not yet clear how the NAD(P)H-driven
conformational change of AIF controls the availability and function of CHCHD4 in the
IMS, the existence of a human mitochondriopathy-associated pathogenic mutation of
AIF (G308E), which is located within its NAD+/NADH-binding domain and impairs the
interaction with CHCHD4, is an indicator of the relevance of NADH/NADPH homeostasis
in the physiological functioning of the MIA import pathway [52,88].
A summary of the important small redox-active molecules associated with redox
regulation in the mitochondrial IMS discussed in this section is given in Table 2.
Antioxidants 2021, 10, 592 13 of 19
Table 2. Small redox-active molecules associated with redox regulation in the mitochondrial IMS discussed in this review.
Molecule Name Function References
Hydrogen peroxide (H2O2)
H2O2 is a small molecule oxidant and can easily pass through the
mitochondrial membranes. H2O2 is produced by Erv1/ALR when
electrons are passed to molecular oxygen as part of the cycle to
re-oxidise Mia40. Additionally, H2O2 can directly oxidise select
cysteine residues to induce signalling through structural changes in
the protein. Trx1 is usually the enzyme that reduces disulphide
bonds created by H2O2.
[5,10,41–44,47,61,68–71]
Glutathione (GSH)
A component of the glutaredoxin system, GSH has various roles in
the reduction of disulphide bonds. The majority of GSH in cells is in
the reduced form of GSH. The ratio of reduced/oxidised GSH is a
measure of oxidative stress. The GSH redox potential in the IMS is
linked to the cytosol, and the two pools of GSH are kinetically
connected. GSH in the IMS has been proposed to increase the rate of




NADPH is an important cofactor and electron donor, influencing
both the glutaredoxin and thioredoxin systems and may have a
critical role in redox homeostasis in the IMS.
NAD(P)H-dependent redox control influences the interaction of
CHCHD4 with AIF via dimerisation of AIF in human cells.
[45,52,77–88]
6. Interplay of Proteins and Small Molecules in Fe-S Cluster Biogenesis and Calcium
Signalling in the IMS
As the IMS is a constricted compartment, there is likely to be some communication
between the different proteins involved in the IMS machinery and other IMS-related
pathways, particularly signalling pathways. It has previously been suggested that there is
crosstalk between the mitochondrial GSH and Trx systems in the matrix, which does not
occur in the cytosol [72]. We propose that a similar crosstalk may also occur in the IMS to
maintain the redox state of this sub-compartment. This section will discuss the potential
links of the IMS-localised and redox-regulated MIA pathway to (i) iron-sulfur clusters and
(ii) calcium signalling, highlighting both the small molecules and the proteins that could be
involved (Figure 4).
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6.1. Iron–Sulfur Clusters
Iron–sulfur clusters (ISCs) are cofactors, specifically metal prosthetic groups that
are involved in a wide range of cellular pathways such as protein translation, energy
production, and DNA replication and repair [89,90]. The simplest ISC is the rhombic
2Fe-2S, which can be found in ETC complexes I and II, whilst duplication of the rhombic
form results in the cubic 4Fe-4S form. ISCs are highly reactive, which is a characteristic
that makes them suitable for a range of catalytic reactions, and susceptible to oxidation,
which leads to their inactivation [90–92]. There are three identified assembly pathways of
ISCs: two are present in the mitochondria and one is present in the cytosol. Both the ISC
assembly system and the iron–sulfur exporter (ISE) system are present in the mitochondria,
while the cytosolic iron–sulfur assembly system (CIA) is present in the cytosol [1,91]. There
are potential links between IMS-localised Mia40-dependent machinery and ISCs (Figure 4),
which first emerged in 2013 when Mia40 was found to bind a 2Fe-2S cluster in a dimer form.
The ISC bound to reduced Mia40 was proposed to be coordinated by the cysteine residues
of the redox-active CPC motif of two Mia40 molecules, and the addition of H2O2 (which
oxidises Mia40) leads to the disassembly of the ISC [93]. Additionally, the authors raised
questions on whether changes in the two populations of Mia40 in the IMS, one oxidised (not
bound to iron) and the other reduced (apo ISC bound), have a role in responding to external
stimuli, as high levels of H2O2 lead to ISC dissociation [93]. Interestingly, human Mia40
(CHCHD4) has also been suggested to play a role in the export of ISCs, with depletion of
CHCHD4 resulting in the accumulation of iron in mitochondria, along with a decrease
in the activity and stability of cytosolic Fe-S containing enzymes. It was speculated that
since the CPC motif of Mia40 is required for both protein import and ISC binding, the
redox environment of the IMS could have an effect on influencing the function of Mia40
either in protein import or in the export of ISC [89]. However, overall, the role of Mia40 in
regulating cellular iron homeostasis is still disputed, and the exact role of redox-regulated
Mia40 in the biogenesis of ISCs remains to be fully dissected. It is important to consider
that a population of Mia40 must be kept reduced (potentially by Trx1 or GSH) to allow
interaction with ISCs and perhaps facilitate ISC export.
6.2. Calcium Signalling
Calcium uptake into mitochondria of higher eukaryotes is mediated by the mitochon-
drial calcium uniporter (MCU), which is an IMM-anchored calcium-conducting protein
that functions in concert with regulatory proteins MICU1 (Mitochondrial calcium uptake 1)
and MICU2 (Mitochondrial calcium uptake 2). The MCU-mediated uptake of calcium is
driven by the membrane potential of the IMM [94]. During evolution, some species of
yeast including S. cerevisiae have lost MCU and instead contain MCU homologs [95]. Tight
control of calcium uptake by mitochondria is essential due to the critical role of calcium
in cell death, autophagy, and activating three Krebs cycle dehydrogenases, which in turn
affect ATP production via OXPHOS. Other components of the human MCU include the
MCU paralog MCUb, which has 50% similarity to MCU and a similar structure differing
slightly in a loop region, and EMRE, which is a small IM 10 kDa protein [96]. Recently, two
homologs of the scaffold factor of MCU (MCUR1) were identified in S. cerevisiae, namely
Put6 and Put7 but with a role in proline metabolism [97]. Interestingly, MICU1, which is
one of the regulator partners of MCU and therefore calcium uptake, resides in the IMS,
which may explain how mitochondria respond to calcium levels in the cytosol [12]. MICU1
regulates MCU by keeping the pore closed when there is a low level of calcium, and it
mediates the pore opening when higher calcium concentrations are available to facilitate
calcium transport across the IMM. A Mia40 interactome study identified MICU1 as a Mia40
interactor, therefore linking disulphide bond formation to calcium signalling [98]. MICU1
contains a matrix-targeting signal of 33 residues, making its import independent of Mia40
and instead dependent on the membrane potential of the IMM. Mia40 was reported to
be responsible for introducing an intermolecular disulphide bond, which promotes the
heterodimerisation of MICU1 to MICU2: MICU2 inhibits MICU1 and does not interact with
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Mia40. When this disulphide bond is introduced to MICU1 by Mia40, association of the
MICU1–MICU2 heterodimer with MCU is dependent on IMS calcium levels. Association
occurs when there is a low level of calcium present, and dissociation occurs when there is a
high level of calcium. It is noteworthy that the disulphide between Mia40 and MICU1 was
found only when the membrane potential was intact [98]. Overall, this interaction with
Mia40 provides a link between the regulation of calcium uptake by the mitochondria and
the redox-regulated oxidative folding machinery in the IMS, as regulators of mitochondrial
calcium signalling (MICU1 and MICU2) are resident in the IMS (Figure 4).
7. Conclusions and Future Outlook
In this review, we have highlighted some critical aspects of how redox regulation
and signalling converge in the mitochondrial intermembrane space at the MIA pathway.
Optimal operation of these processes requires a finely tuned interplay between proteins and
small molecules. Despite several important advances in identifying the important players
and in elucidating some of the key mechanisms, our understanding is not yet complete.
Several proteins components that we have discussed in this review have been identified
as regulators or potential interactors of the disulphide relay machinery, but it is not clear
whether they operate in a constitutive manner or they are part of mechanisms activated
in response to metabolic changes or stress conditions. Furthermore, small molecules and
ROS, which can also influence the function of the MIA machinery need to be kept under
balance and detoxified to avoid deleterious effects and keep them within a concentration
regime that is beneficial for signalling and not detrimental. Furthermore, the influence of
the most damaging ROS generated in mitochondria (the super oxide anion), which has
at least eight sites of production [99], is unclear and will be the subject of future studies.
For example, additional effects of ROS on lipid peroxidation, which can cause membrane
damage and lead to further ROS production, are very poorly understood.
The critical link of the MIA machinery to generalised mitochondrial dysfunction
and human disease is exemplified by at least three different axes. First, the mutation or
abnormal expression of components of the MIA machinery and its interactors such as AIF
are involved in several human diseases [26,55]. Second, substrates of the MIA pathway are
linked also to primary mitochondrial diseases (such as several mitochondriopathies related
to COX deficiencies) and to more common neurodegenerative diseases (such as for example
CHCHD2 and CHCHD10, which are linked to amyotrophic lateral sclerosis) [100]. Finally,
CHCHD4 has recently been found to be required for PINK1 stabilisation in the absence
of mitochondrial membrane potential, whilst the inhibition of CHCHD4 by antioxidants
such as GSH could suppress PINK1 accumulation [101]. This opens up the possibility
that MIA machinery may have unknown links to PINK1-dependent mitophagy and po-
tentially affect not just mitochondria biogenesis but more broadly mitochondria quality
control [102]. This represents an interesting example of two distinct types of signalling
cues: redox-signalling and phosphorylation-signalling converging at the mitochondria
via the MIA system. In broader terms, fully teasing out the molecular links between
different types of regulation and signalling as they coalesce at the intermembrane space
could advance our understanding of mechanisms that maintain mitochondrial fitness and
could help the development of potential therapeutic targets in human diseases relating to
mitochondria dysfunction.
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